Related Experiment Video

Updated: Jun 12, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Casein Kinase II: an attractive target for anti-cancer drug design

Ismail Muhamad Hanif1, Ibrahim Muhammad Hanif, Muhammad Ali Shazib

  • 1Experimental Therapeutics Centre, Agency for Science, Technology and Research (A*STAR), Singapore.

The International Journal of Biochemistry & Cell Biology
|June 19, 2010
PubMed

Insights

Casein Kinase II (CK2) is a vital enzyme regulating cell growth. Its elevated activity is linked to cancer, making CK2 a promising target for new anti-cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Casein Kinase II (CK2) is a highly conserved serine/threonine kinase in eukaryotic cells.
  • CK2 plays a critical role in regulating cell growth, proliferation, and survival.
  • Increased CK2 expression and activity are implicated in human cancers and cellular transformation.

Purpose of the Study:

  • To provide a concise overview of CK2 biology.
  • To highlight CK2's substrates and its role in pro-survival and pro-proliferation.
  • To summarize evidence linking CK2 to human carcinogenesis.

Main Methods:

  • Literature review of CK2 biology and cancer relevance.
  • Analysis of experimental evidence on CK2 function.
  • Synthesis of data on CK2's role in cellular transformation.

Main Results:

  • CK2 regulates numerous growth-related proteins.
  • CK2 activity promotes cancer cell survival and proliferation.
  • Genetic and pharmacological inhibition of CK2 sensitizes cancer cells to apoptosis.

Conclusions:

  • CK2 is a key regulator of cell fate in cancer.
  • CK2-specific therapies are of significant interest for cancer treatment.
  • Understanding CK2 biology is crucial for developing targeted cancer therapies.

More Related Videos

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...